Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01537796 · ClinicalTrials.gov registry record · NA
Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT01537796: Completed NA study, sponsored by University of Pittsburgh.
NCT01537796 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01537796, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effect of an enhanced technology-based system, that involves a wearable device to measure calories burned combined with a website, in comparison to previous versions of similar technology and a standard behavioral weight loss on body weight across 6 months in obese adults.
Interventions
- BEHAVIORAL In-Person weight loss
- BEHAVIORAL FIT weight loss
- BEHAVIORAL FIT-BT weight loss
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-07 |
| Phase | NA |
What the finished NCT01537796 record still lists
NCT01537796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which In-Person weight loss is the first listed.
NCT01537796 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01537796 about?
NCT01537796 is a clinical study titled "Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese". The purpose of this study is to examine the effect of an enhanced technology-based system, that involves a wearable device to measure calories burned combined with a website, in comparison to previous versions of similar technology and a standard behavioral weight loss on body weight across 6 months...
What is the current status of trial NCT01537796?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2012-02. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01537796?
The interventions under investigation include: In-Person weight loss (BEHAVIORAL), FIT weight loss (BEHAVIORAL), FIT-BT weight loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT01537796?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01537796's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia